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Abstract
Purpose Intensive therapies in pediatric malignancies increased
survival rates but also occurrence of treatment-related morbid-
ities. Therefore, supportive care fulfills an increasingly impor-
tant role. In planning development of guidelines with incorpo-
ration of shared decision making, we noticed that little is known
about the needs and preferences of patients and their parents.
Our goalswere therefore to investigate (1) which supportive care
topics patients and parents regard as most important and (2) the
preferred role they wish to fulfill in decision making.
Methods This qualitative study consisted of three focus groups
(two traditional, one online) with patients and parents of two
Dutch pediatric oncology centers. Data were transcribed as
simple verbatim and analyzed using thematic analysis.
Results Eleven adolescent patients and 18 parents shared de-
tailed views on various aspects of supportive care. Themes of
major importance were communication between patient and
physician (commitment, accessibility, proactive attitude of
physicians), well-timed provision of information, and the suit-
ability and accessibility of psychosocial care. In contrast to
prioritized supportive care topics by medical professionals,
somatic issues (e.g., febrile neutropenia) were infrequently
addressed. Patients and parents preferred to be actively in-
volved in decision making in selected topics, such as choice
of analgesics and anti-emetics, but not in, e.g., choice of
antibiotics.
Conclusions Children with cancer and parents were provided
a valuable insight into their views regarding supportive care
and shared decision making. These results have important
implications towards improving supportive care, both in
selecting topics for guideline development and incorporating
preferences of patients and parents herein.
Keywords Supportive care . Pediatric oncology . Focus
group . Shared decisionmaking . Evidence-based guidelines .
Patient involvement
Introduction
During the previous five decades, the five-year survival
rates for children with cancer in Europe and the USA
have risen to more than 80% for all childhood cancer
types combined [1–4]. However, these improvements
have led to a growing population of patients (and survi-
vors) experiencing short- and long-term treatment-related
diseases and side effects [5–7]. These morbidities may
even lead to delays, lowering or premature termination
of treatment, consequently reducing individual survival
chances, and hence increasing mortality [8–10].
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Supportive care (SC), which comprises management of
both physical and psychological side effects of treatment, ful-
fills an important role in reducing morbidity and mortality and
increasing quality of life, and should thus be optimized [11,
12]. To provide optimal SC, clinical practice should be based
upon the best evidence available. To achieve this transition of
evidence to practice, development of clinical practice guide-
lines (CPG) is needed. A CPG is defined as Ba statement that
includes recommendations intended to optimize patient care
that are informed by a systematic review of evidence and an
assessment of the benefits and harms of alternative care op-
tions^ [13]. Currently, most guidelines in SC in childhood
cancer are not evidence-based, contradictory, or outdated
[14–16]. Well-developed, evidence-based guidelines in this
area are limited to febrile neutropenia and nausea/vomiting
[17–19].
In order to prioritize SC topics for the development of
CPGs, the opinion of medical professionals has previous-
ly been determined [20]. Following this, we aimed to
explore views of patients and parents using focus groups
to determine which SC topics they regard as most impor-
tant, as we consider it essential to incorporate this in our
CPG development project. The decision for a qualitative
research (QR) method (e.g., in-depth interviews, focus
groups (FGs)) instead of quantitative research was based
on the more explanatory and flexible nature of QR to
generate subjective and profound information from poorly
explored areas [21–24]. Within QR, FGs are often used in
healthcare research and considered most suitable to elicit
information about the norms and experiences of a group
and are thus applicable to generate a broad overview of
topics of interest [23, 25, 26].
Over the last two decades, a global trend has grown
towards shared decision making (SDM) and acknowledg-
ing children’s right to participate in matters that affect
them [27]. Since pediatric oncology treatment has become
increasingly complex, patients and their families are more
frequently faced with complicated treatment decisions
[28]. Studies on parents of children with cancer showed
that autonomy-based health care is preferred over a pater-
nalistic approach [29, 30]. However, it was shown that
currently adolescent patients fulfilled a minimal role in
SDM but desired information on treatment decisions
[31]. To facilitate SDM, knowledge of patients’ and par-
ents’ preferred involvement in decision making should be
incorporated within CPGs.
Therefore, the aim of this study was bipartite:
(a) To determine which topics within SC pediatric cancer
patients and their parents regard as important
(b) To investigate the role pediatric cancer patients and their
parents wish to fulfill in SC decision making
Methods
Study population
This study was conducted in the University Medical Center
Groningen (UMCG) and the Academic Medical Center
(AMC) Amsterdam between April 2015 and December
2015. The pediatric oncology departments in both hospitals
each have approximately 90 new patients per year. The psy-
chosocial care team (psychologists, social workers, and child
life specialists) covers five full time equivalents (FTEs) in the
AMC, compared to three FTEs in the UMCG.
We conducted separate FG meetings among patients and
parents since we expected that in these groups different topics
and priorities would be discussed. During the study, recruit-
ment of adolescent patients for a live meeting proved to be
problematic for personal and organizational reasons (e.g., pa-
tients prioritized other activities on the day of the FG meet-
ings). Hence, we conducted two traditional focus groups
(TFGs) with parents and one more adolescent-appropriate on-
line focus group (OFG) with adolescent patients [25].
Parents in the TFG were eligible to participate if their child
was 0–18 years at the time of diagnosis of childhood cancer;
patients in the OFG were eligible if they were aged 12–
18 years at time of diagnosis. All patients and children of
the parents had to be on treatment for a minimum of 2 months
at the time of selection or within 6 months after termination of
treatment. To create FGs as diverse as possible, purposeful
sampling based on diagnosis, age, and duration of treatment
was performed by oncologists from the participating centers
and via the patient organization ‘Dutch Cancer Association for
Children and Parents’ (VOKK) [32]. As a token of apprecia-
tion, all participants (both parents and patients) received a gift
card.
This study was approved by the Medical Ethical
Committee of the UMCG.
Focus group design, data collection, and analysis
In a TFG, six to ten persons are led through an open discussion
by an experienced and neutral moderator to examine a specific
topic or set of issues [33–35]. In an OFG, for instance, a
secured online forum, participants anonymously respond to
posted topics and to the comments of the moderator and fel-
low participants [25]. In this study, we conducted two 2 hours
TFGs that were moderated by a social psychologist with ex-
tensive TFG-moderator experience. The moderator was fully
informed by the researchers about the topic and the study
aims. Two researchers attended the TFGs to take notes and
assist the moderator if necessary. The moderator and re-
searchers were unacquainted with the parents. Questions were
composed by the researchers and checked and revised by the
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social psychologist to ensure that all questions were open,
broadly formulated, applicable to the target group, and in line
with the research objectives (Table 1). While we did complete
a prior SC prioritization effort among medical professionals,
these outcomes were not taken into account when composing
the FG questions [20]. This approach was chosen as we be-
lieved it was essential to get a clear and an unbiased overview
of insights and to explore differences in preferred SC topics
among patients and parents versus medical professionals.
Before the TFGs, all parents completed a short socio-
demographic questionnaire. A local childhood oncologist
attended the first 15 min of the TFGs to inform parents about
SC and the aims of the study. Thereafter, the moderator intro-
duced the FG procedure in general and the ground rules (e.g.,
speaking one by one).
The OFG was performed using a specifically designed,
secured online forum. To ensure anonymity during the OFG,
all 11 patients received a personal, anonymous login name and
password and were asked not to mention names or share pri-
vate information. The questions asked in the OFG were de-
rived from overarching principal themes identified from the
TFGs to ensure continuity of topics and to be able to compare
the outcomes (Table 2). We posted an opening question to
inform patients about SC, the aims of the study, and the pro-
cedure. During a 2-week period, each weekday at 10:00 a.m.,
we posted a new question with a short explanation. A moder-
ator actively participated in the OFG to ask for clarification in
case of ambiguous comments and to encourage non-
responding patients.
Both TFG meetings were audio recorded using a digital
Tascam DR-100 MKII audio recorder and the record function
on a mobile phone as backup. These audio recordings were
transferred to a secured computer and deleted from both de-
vices after the meetings ended in order to guarantee privacy.
Subsequently, the audio files were loaded into the application
ATLAS.ti version 7.5.6 (Cleverbridge AG, Berlin, Germany)
to be transcribed as simple verbatim. After transcription, tran-
scripts were proofread by one researcher (LT) to eliminate
major typographical errors. Qualitative data from the OFG
were copied from the secured forum and incorporated in
ATLAS.ti.
Table 1 Semi-structured discussion guide used in the traditional focus
group sessions (TFG)
Opening question
- Could you introduce yourself and share your child’s diagnosis with us?
Key questions
Objective 1. To determine which topics within supportive care patients
and parents regard as important
- How did you experience supportive care?
- What went well in the current supportive care, what went wrong? And
why did this go well/wrong?
- What do you miss in the current supportive care?
- What topics often caused confusion between different doctors/nurses or
different hospitals?
- What would you like to change in these topics in the supportive care?
Objective 2. To investigate the role pediatric cancer patients and their
parents wish to fulfill in supportive care decision making
- Which role have you played in making decisions in supportive care?
- Which role would you like to play in making decisions about treatment?
-With which topics would you like to think along with doctors/nurses and
with which topics would you not?
- Would you appreciate it to talk separately from your child with the
doctor regarding some topics and if so, which topics?
Final questions
- Do you have any other comments?
- Are there any topics you would like to address, which we have not
talked about?
Table 2 Topics with explanation as posted on the forum at the OFG
Day 1 Care in the hospital
Explanation
A lot happens at the hospital in the area of supportive care: You receive
medication for pain or nausea, you talk with psychosocial staff (such as
a teaching assistant, or perhaps a psychologist), you get your food at
the pediatric oncology ward, you have to get to the operation center in
isolation, and so on. Would you like to share your experience in the
hospital? This should of course be both positive and negative. You can
talk about anything, about the hospital, both the clinic and the
department(s), the emergency department, the operations center, the
pharmacy, and so on.
Question
In the hospital, a lot happens in addition to the main treatment (giving
chemotherapy, radiation therapy). What do you experience? And how
do you feel about it?
Day 2 Care at home*
How do you manage things at home on the area of supportive care?
Day 3 Communication*
What do you think of the way people communicate with you?
Day 4 Provision of information*
Are you satisfied with the information you get and questions people ask
you? And what do you think of the ways you get this information?
Day 5 Psychosocial care*
Psychosocial care is all about how you feel, emotionally and socially.
How do you experience this type of care?
Day 6 Physical care*
How do you experience the physical medical care?
Day 7 Shared decision making*
Which role do you prefer to play in making decisions about supportive
care during your treatment?
Day 8 Remaining topics*
Are there any other things related to the care for your illness that you
would like to share?
* Each question was posted along with an explanation. Above, only the
explanation of day 1 is showed
Support Care Cancer (2017) 25:3151–3160 3153
Thereafter, all transcripts were thoroughly read, and the-
matic analysis was performed to identify recurring topics
and to create meaningful themes within the data [36, 37].
Themes were converted into codes and then organized into
larger clusters. Subsequently, each quote was coded by using
this coding scheme and on its overall assessment of care (pos-
itive, negative, or neutral) by two researchers (LT, EL) inde-
pendently. A quote could be labeled with one or more codes
since a quote could fit within more than one category.
Corresponding codes were retained in the combined docu-
ment while dissimilar codes were discussed until consensus
was reached (third party arbitration was not necessary).
Regarding ranked importance of topics, we decided to com-
pose a quantitative ranking list using the numerical frequency
of occurrence of the codes.
Results
Participants
In total, 53 parents and patients were approached of which 29
(54.7%) eventually participated (Fig. 1). Nine fathers and nine
mothers with a median age of 44 years (range 29 to 56 years)
attended the TFGs (Table 3). Most of them were parents of a
child diagnosed with acute lymphoblastic leukemia (ALL,
n = 9, 50.0%). The median period of treatment was 13months
(range 3 to 66 months). Five girls and six boys with a median
age of 15 years (range 12 to 18 years and a median period of
treatment of 23.5 months, range 2 to 27) participated in the
OFG. Most of them (n = 6, 54.5%) suffered from ALL.Fig. 1 Flow chart shows the results of participant selection






Male 9 (50.0%) 6 (54.5%)
Female 9 (50.0%) 5 (45.5%)
Age (years)
Median, range 44 (29.0–56.0)a 15 (12.0–18.0)b
Age child (in years)
Mean, range 11.5 (3–18)
Diagnosis (child)
ALL 9 (50.0%) 6 (54.5%)
Bone tumor 2 (11.1%) 1 (9.1%)
GCT 1 (5.5%) 0 (0.0%)
Brain tumor 2 (11.0%) 1 (9.1%)
STT 4 (22.0%) 3 (27.3%)
Period of treatment (months)
Mean + range 17.2 (3–66) 18.9 (2–27)
Highest level of educationc
Low 5 (27.8%) 10 (90.9%)
Intermediate 6 (33.3%) 1 (9.1%)
High 7 (38.8%) 0 (0.0%)
Place of residenced
Village 10 (55.6%) 6 (54.5%)
City 8 (44.4%) 5 (45.5%)








Within the sample of 18 parents, three parent-parent couples and three
child-parent couples were included leading to the characteristics being
included in the descriptive statistics twice. These data have been included
in the descriptive statistics since this analysis concerns participants’ back-
grounds, and their judgments are correlated with this
SD standard deviation, ALL acute lymphatic leukemia, GCT germ cell
tumor, STT soft tissue tumor
a Age at 1 April 2015
bAge at 1 December 2015
cHighest education is reported. Low = primary education, general sec-
ondary education; Intermediate = secondary vocational education;
High = higher vocational education and university
d A place of residence with a population >50,000 inhabitants is labeled as
a city
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Determination of important topics
Characteristics of the responses are shown in Table 4.
Fifty-six codes were described and organized in five larg-
er clusters: care in the hospital (q = 247, q = number of
quotations), communication (q = 214), psychosocial care
(q = 175), care at home (q = 104), and somatic care
(q = 80). Thereafter, 826 quotations were coded by the
coding scheme as showed in Table 5. The assessment of
care was quoted as negative (q = 453), positive (q = 332),
or neutral (q = 52). The topic concerning communication
between physician and patients was quoted as both most
negative (q = 34) and most positive (q = 35). In general,
parents’ quotes were more often labeled as negative than
patients’ quotes (64.1 and 23.4%, respectively). Topics at
which there was clear and quick consensus among the
participants were Bexchange tips among parents^ (nega-
tive; currently few facilities to do so), Bcommunication
between different departments^ (negative; currently mis-
communication on treatment agreements), and Bcommuni-
cation on nutritional advice^ (negative; currently lack of
nutritional guidelines). For practical reasons, the ten most
quoted codes are represented below; the full and detailed de-
scription of all codes is available in the supplemental data.
Care in the hospital
Regarding the pediatric oncology ward and outpatient clinic,
participants (both patients and parents) felt that they were suffi-
ciently cared for. Participants felt at home when they visited the
pediatric oncology ward, the outpatient clinic, and the single day
admission. In contrast, participants missed a stimulus to be phys-
ically active, e.g., dinner was currently often served in bed in-
stead of at the table. Regarding comfort, parents felt that a quiet
place to conduct private conversations and a sufficient, clean, and
private cooking facilities were important. To reducewaiting time,
participants appreciated that several appointments in the hospital
were clustered, and that arrangements were made to visit the
pediatric oncology ward immediately in case of an emergency.
Communication
Participants were satisfied with the communication they re-
ceived from physicians. The commitment, accessibility,
explaining, and proactive attitude in decisions about treatment
and treatment options strengthened their relationship.
Participants positively valued that information on diagnosis,
and treatment was provided in a phasedmanner, adapted to the
stage they were in. However, practical information, such as
available forms of administering medicines, was often provid-
ed too late. Participants acknowledged there was great de-
mand for information at the beginning of the process, but little
energy and time to search for it.
Psychosocial care
Patients shared that they had to cope with a great deal, espe-
cially during the first weeks of treatment. The support provid-
ed by physicians, nurses, and social workers through talking
about positive things was appreciated. Furthermore, partici-
pants expressed that physicians frequently asked how they felt
mentally and appreciated that they could always contact the
physician. Participants felt physicians would notice it when
they did not feel well.
Many patients and some parents reported to have searched for
specialized psychological support during various stages of treat-
ment. They were satisfied with the specialized psychological
support from both the hospital and the specialized psychological
centers. However, making an appointment with a psychologist
was often difficult. Participants regretted the absence of a period-
ic assessment regarding whether the patient, parents, or siblings
had psychological needs. Furthermore, since the need for support
varied with age and phase of treatment, patients shared that psy-
chosocial care should adapt to these differences.
BWell, I expected some more guidance from the child life
specialists with my daughter. We had bad luck with
changing psychologists so we had about 6 different
Table 4 Characteristics of response in both focus groups
TFG OFG
Total number of quotes/postings 643 76
Quotes/postings per topica 11.5 (1–28) 9.5 (2–14)
Total participants 18 17
Active participants 18 11
Quotes/postings per participanta 35.7 4.5 (1–11)
Average time spent on the foruma 39.6 min
(0.6 min–78 min)
Total views 284
Views per topica 38.5 (4–66)
Day Topic Quotes Views
Day 1 Care in the hospital 10 66
Day 2 Care at home 14 58
Day 3 Communication 9 42
Day 4 Provision of information 8 35
Day 5 Psychosocial care 8 36
Day 6 Physical care 7 34
Day 7 Shared decision making 7 36
Day 8 Remaining topics 2 11
Data includes the topic on Bremaining comments,^ does not include the
topic Bquestions,^ and includes non-reacting participants. As one quote
was classified by several codes, the number of coded quotes is not equal
to the total number of quotes
a Reported are means and ranges
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Table 5 Number of quotes per code
Code BFGs TFG OFG
Total Value assessment Total Value assessment Total Value assessment
+ − + − + −
1. Care in the hospital
Care at the departments
Pediatric oncology ward 36 12 11 27 5 9 9 7 2
Outpatient clinic of pediatric oncology 23 16 2 15 9 1 8 7 1
Emergency department 17 5 14 13 0 14 4 5 0
Operation center 10 0 7 10 0 7 0 0 0
Single day admission 4 2 2 4 2 2 0 0 0
Facilities at the hospital
Comfort for parents 21 5 14 21 5 14 0 0 0
Privacy (e.g., room layout) 20 2 16 19 2 15 1 0 1
Hygiene 11 1 11 11 1 11 0 0 0
Parking 6 0 6 6 0 6 0 0 0
Comfort for the patient 5 2 2 5 2 2 0 0 0
Making decisions at the hospital
Management of medication 23 16 6 22 9 6 1 7 0
Management of nutrition 6 0 6 6 0 6 0 0 0
Waiting time at the hospital 21 6 14 20 5 13 1 1 1
Intervene in treatment 16 1 8 16 1 8 0 0 0
Movement and activation 11 2 7 10 2 7 1 0 0
Exchange tips among parents 10 0 7 10 0 7 0 0 0
Patient record management 7 0 7 7 0 7 0 0 0
Total care in the hospital 247 70 (33.3%) 140 (66.7%) 222 43 (24.1%) 135 (75.8%) 25 27 (84.3%) 5 (15.6%)
2. Communication
Within the hospital, between:
physician and patient 42 34 35 28 13 28 14 21 7
nurse and patient 17 16 17 8 8 14 9 8 3
physician and physician 11 1 10 11 1 10 0 0 0
different departments 10 0 7 10 0 7 0 0 0
patient and other staff 9 1 4 9 1 4 0 0 0
physician and nurse 5 1 6 5 1 6 0 0 0
Provision of information 41 11 21 26 3 18 15 8 3
Shared decision making 22 19 5 14 11 4 8 8 1
Separate consultation (child/parent) 19 13 3 16 11 3 3 2 0
Communication between hospitals 14 3 7 14 3 7 0 0 0
Case-manager 11 1 10 11 1 10 0 0 0
Nutritional advice 10 0 8 10 0 8 0 0 0
Between GP and oncologist 3 1 1 3 1 1 0 0 0
Total communication 214 101 (43.0%) 134 (57.0%) 165 54 (31.0%) 120 (69.0%) 49 47 (77.0%) 14 (23.0%)
3. Psychosocial care
Psychosocial support
For patient 30 22 13 20 10 8 10 12 5
By specialized psychosocial care 25 21 15 17 11 10 8 10 5
For parents 17 6 10 17 6 10 0 0 0
By social workers 17 4 14 15 3 13 2 1 1
By child life specialists 12 6 7 6 5 5 6 1 2
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people. We receive the beads from her but, well, she
doesn’t ask, gosh can we do something for you? I truly
expected that they would be more involved.^
41-year-old mother of a nine-year-old son suffering
from ALL
Care at home
All participants viewed going to school as very important
since at school they did not feel like a patient and could inter-
act with their classmates. Hospitalization and fatigue were the
most frequent reasons for them being absent. Proper arrange-
ments on attending school were made, and various solutions
were invented to allow classes to be followed from home or
the educational provision at the hospital.
BAt school, everything is arranged really well. If I have
to go to the hospital for chemotherapy or a dose, I can
easily go without any problems. All teachers are aware
and understand if I want to leave class, for a breath of
fresh air for example.^
18-year-old patient suffering from ALL
Table 5 (continued)
Code BFGs TFG OFG
Total Value assessment Total Value assessment Total Value assessment
+ − + − + −
For siblings 10 6 1 10 6 1 0 0 0
Difference between child and adolescent 4 0 4 4 0 4 0 0 0
Empathy
Of nurses 20 3 11 18 2 10 2 1 1
Of physicians 15 4 9 10 3 7 5 1 2
Of the environment 13 10 3 4 3 1 9 7 2
Of other professionals 12 4 3 9 3 3 3 1 0
Total psychosocial care 175 86 (48.9%) 90 (51.1%) 130 52 (41.9%) 72 (58.1%) 45 34 (65.4%) 18 (34.6%)
4. Care at home
School 23 15 5 11 6 3 12 9 2
Movement and activation 23 13 5 13 7 3 10 6 2
Nutrition at home 17 1 7 17 1 7 0 0 0
Treatment options at home 17 11 8 13 7 6 4 4 2
Role of GP 15 11 2 15 11 2 0 0 0
Restrictions in daily life and activities 9 4 4 8 3 4 1 1 0
Total care at home 104 55 (64.0%) 31 (36.0%) 77 35 (58.3%) 25 (41.7%) 27 20 (77.0%) 6 (23.0%)
5. Somatic care
Nutrition at the hospital 16 3 16 14 3 15 2 0 1
General somatic care 15 3 5 9 1 5 6 2 0
Nutrition 14 3 11 13 2 11 1 1 0
Nausea-vomiting 13 5 9 7 0 9 6 5 0
Pain 7 6 4 2 2 4 5 4 0
Fatigue 6 6 1 0 0 0 6 6 1
Muscle weakness and reduction of strength 5 4 2 0 0 0 5 4 2
Infection 3 0 5 3 0 5 0 0 0
Anemia 1 0 1 1 0 1 0 0 0
Total somatic care 80 30 (35.7%) 54 (64.3%) 49 8 (13.8%) 50 (86.2%) 31 22 (84.6%) 4 (15.4%)
Total 826 332 (42.3%) 453 (57.7%) 648 175 (30.2%) 405 (69.8%) 178 157 (76.6%) 48 (23.4%)
Number of quotes per code. Note 1: As one quote was classified by several codes, the number of coded quotes is not equal to the total number of quotes.
Note 2: The total number of quotations is not necessarily the sum of all positive and negative quotations; quotes are double valued at times. Neutral
quotations are not shown
FGs both focus groups, + = positive assessment of care, − = negative assessment of care
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The degree of suffering from side effects such as fatigue
and loss of strength varied among patients. All patients agreed
that physical therapy helped to restore their strength. They felt
that their physical condition was properly taken into account
at school and at sport clubs, resulting in participation in sports
practice as much as possible. In contrast, parents of adolescent
patients experienced difficulties in motivating their child to be
more physically active and wished to receive more support.
Somatic care
This topic was scarcely mentioned. Full and detailed descrip-
tions of these codes are available in the supplemental data.
Determination of topics concerning shared decision
making
The preferred role in SDMwas investigated by analysis of the
following five codes: Bshared decision making,^ Bdecisions
concerning medication,^ Bdecisions concerning nutrition
management,^ Bintervening in treatment,^ and Btreatment op-
tions at home.^ In all FGs, participants appreciated autonomy
and active involvement in making decisions about their/
child’s treatment, particularly regarding decisions about med-
ications to diminish side effects (e.g., analgesics). Participants
often consulted the physician to discuss a medical decision
and were satisfied with the non-compelling way of receiving
information and the options they were offered, such as com-
posing personalized medication schemes. Regarding specific
types and doses of medication (e.g., antibiotics in febrile neu-
tropenia), participants relied on and trusted the physicians’
advice, since they felt of lack sufficient knowledge.
Participants shared that they preferred to manage the admin-
istration of medication and nutrition on their own behalf and
desired time without interference of health care professionals,
both at home and at the hospital. Regarding care in the hospi-
tal (e.g., administration of medication), several parents felt
they had to be constantly aware (and to explicitly check) that
care was being performed as agreed upon.
Discussion
To our knowledge, this is the first study that explores the
experiences, needs, and preferences regarding SC of children
with cancer and their parents. Themes of major importance
were communication between patient and physician (i.e., the
accessibility and proactive attitude of physicians), the well-
timed and balanced provision of information, psychosocial
care, and facilities to be physically active. A notable finding
was the emphasis of parents on practical aspects, such as room
layout and privacy, parking facilities, and hygiene. In contrast
to prioritized SC topics by medical professionals, somatic
issues such as anemia and infections were infrequently ad-
dressed, with the exception of nutritional issues [20].
With regard to SDM, patients and parents shared to fulfill
an active role in decision making regarding the use of medi-
cation to diminish side effects at home and in the hospital and
wished this to remain so. This is in accordance with previous
research in the field of pediatric palliative care [29]. The pro-
vision of well-timed, complete, and accurate information is
considered to be a major condition for achieving SDM, which
is in line with previously published work on provision of care
to parents of children with cancer [38]. As participants felt to
have insufficient knowledge on specific types of medication
(e.g., antibiotics), they relied on and trusted the physicians’
advice. Some parents did however wish to be involved in
checking medication (i.e., agreed type and dose) in the hospi-
tal before it was administered to their child.
Interestingly, patients addressed somatic topics, empathy of
the social environment, and going to school relatively more
often than parents. Furthermore, quotes concerning fatigue,
muscle weakness, and reduction of strength were made exclu-
sively by patients, probably because parents can only estimate
these from observation.
Notably, with 76.6% of patient’s quotes and only 27.7% of
parent’s quotes assessed as positive, patients appeared to be
more positive towards the supportive care they received. This
might be explained by the more structured and closed nature
of OFGs and the fact that various parents made assenting
quotes on certain negative topics. Remarkably, communica-
tion between physician and patients was quoted both most
negative and positive, which could be explained by the large
amount of engagement on this topic.
Although these data were collected in the context of guide-
line development, participant’s insights and suggestions were
often practical and easy to implement. Therefore, the feedback
including practical improvements was shared with the partic-
ipating pediatric oncology wards. Organizing discussion
groups could thus function as an evaluation of SC in general.
In addition, parents mentioned that they liked sharing experi-
ences and tips with parents in the same situation. Conducting
support groups could therefore be of great value for this
population.
Although this study provides an interesting insight into
patients’ and parents’ experiences, needs, and preferences,
it naturally has its limitations. The selection of importance
of topics on the basis of a number of quotations may
affect validity. The most frequently quoted codes were
not automatically implied to be the most important since
there may be important issues which participants quickly
agreed upon (either in a positive or negative way) and
which were thus not selected quantitatively as of major
importance. Nevertheless, we felt this approach was most
appropriate and provided the best insight into the large
amount of qualitative data.
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Another limitation of this study concerned the possible
selection bias that arose by the purposeful selection of partic-
ipants. This was however necessary to ensure diversity in
composition (e.g., in living environment, age) of the relatively
small groups. Approximately, half of all participating patients
and children of participating parents were diagnosed with
ALL, which could have caused bias. On the other hand, since
ALL is the most common childhood cancer, this study pro-
vides a reflection of daily practice [1]. As patients below
12 years were not included for practical reasons (e.g., difficul-
ties in communicating online) and to ensure unity within the
OFG, this study only represented insights of these patients by
proxy (their parents). Half of all included parents had a child
below the age of 12 years.
Moreover, it should be taken into account that needs are
likely to change in the process of treatment, and this study
provides a status quo description of needs and preferences.
However, by purposefully sampling participants at various
stages in this continuum, insight into their needs from various
angles was ensured.
Since questions asked in the OFG were set in advance, it is
likely that less free association arose than in the TFGs. Also,
we did not pilot these questions which might have affected
their quality. However, all questions were checked and revised
by the social psychologist with broad FG experience to ensure
quality and appropriateness. Furthermore, it is important to
realize that in the OFG setting, the emotions and benefits of
conversation (e.g., fast interaction, non-verbal signs) were
missed, which potentially caused an incomplete scope of the
content. To overcome this, patients were invited to make any
sort of comment since the questions raised at the OFG were
broadly formulated, and the moderator frequently asked them
to elucidate their comments.
In conclusion, this study provides an important insight into
patients’ and parents’ views regarding SC and their preferred
role in SDM. Themes of major importance were communica-
tion (i.e., commitment, accessibility, explaining, and proactive
attitude by physicians) and the well-timed provision of infor-
mation. To improve SC, a larger range of possibilities for
psychosocial care for both patients and parents should be en-
sured. Furthermore, to save time and diminish frustrations,
practical aspects of care should be improved (e.g., hygiene
and making an appointment with the child life specialists or
psychologist).
With regard to SDM, this study provides a worthy addition
to the scarce knowledge regarding SDM in childhood oncol-
ogy. Patients and parents were generally actively involved in
SDM concerning medication management (e.g., anti-emetics)
and wished to remain so. It is noteworthy that patients and
parents in some specific somatic issues (e.g., febrile neutrope-
nia) relied on the physicians’ choice with regard to the specific
type and dose of medication and were not interested to be
involved in these decisions. Overall, healthcare professionals
should take time to adjust the care as much as possible to the
preferences of the child and his/her parents.
Regarding our aims, each described topic yielded impor-
tant implications for both clinical practice and the develop-
ment of CPGs. CPGs in SC can now be developed with the
prioritization of the professionals in mind and incorporating
the preferences of patients and parents. In addition, these re-
sults led us to believe that each CPG should incorporate spe-
cific sections on SDM, thereby increasing their quality and
practical applicability. Summarizing, we believe that this
study is a step towards high-quality patient-centered CPG de-
velopment improves SC in childhood cancer.
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